Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design
{{output}}
Background: As one of the most promising classes of next-generation antibody therapeutics, bispecific antibodies (bsAbs) have gained increasing attention owing to their unique dual-targeting mechanisms. However, current bsAb form... ...
